We are live on ! Find out more
Boaz Weinstein

Boaz Weinstein Saba Capital Management

AUM $3.93B Turnover 31.81%
1-Year Est. Return 2.09%
 

Boaz Weinstein is the founder of Saba Capital Management, a firm known for credit, derivatives, and event-driven strategies. He previously built a major credit trading franchise at Deutsche Bank before launching Saba. Weinstein is also widely followed for activism in closed-end funds and for views on credit markets and volatility.

This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+2.09%
3 Year Est. Return
+37.27%
5 Year Est. Return
+40.27%
10 Year Est. Return
+44.95%
AUM
$984M
AUM Growth
-$40.1M
Cap. Flow
+$91M
Cap. Flow %
9.25%
Top 10 Hldgs %
48.71%
Holding
114
New
17
Increased
26
Reduced
25
Closed
20
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
1.4 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.13%
2 Healthcare 6.99%
3 Financials 1.54%
4 Consumer Discretionary 0.69%
5 Industrials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DSU icon
1
BlackRock Debt Strategies Fund
DSU
$544M
$92.1M 9.36%
8,118,988
+34,532
+0.4% +$378K
2013 Q3
13 quarters
ERC icon
2
Allspring Multi-Sector Income Fund
ERC
$228M
$78.9M 8.02%
6,150,514
+413,987
+7% +$5.22M
2013 Q4
12 quarters
FSD
3
DELISTED
First Trust High Income Long/Short Fund
FSD
$74.1M 7.53%
4,608,556
+1,582,766
+52% +$24.7M
2013 Q3
13 quarters
FTF icon
4
Franklin Limited Duration Income Trust
FTF
$213M
$48.6M 4.94%
4,032,571
+30
+0% +$359
2013 Q4
12 quarters
AVK icon
5
Advent Convertible and Income Fund
AVK
$430M
$38M 3.86%
2,655,279
+155,001
+6% +$2.15M
2016 Q1
3 quarters
AGN
6
DELISTED
Allergan plc
AGN
$32.7M 3.32%
+155,521
New +$32.2M
2016 Q4
0 quarters
AGC
7
DELISTED
Advent Claymore Conv Sec & Incme
AGC
$29.7M 3.02%
5,045,169
+414,037
+9% +$2.32M
2016 Q1
3 quarters
DHG
8
DELISTED
Deutsche High Income Opportunities
DHG
$29.2M 2.96%
2,023,745
– –
2013 Q4
12 quarters
AGN
9
CALL
DELISTED
Allergan plc
AGN
$28.3M 2.88%
+134,900
New +$27.9M
2016 Q4
0 quarters
AOD icon
10
abrdn Total Dynamic Dividend Fund
AOD
$954M
$27.7M 2.82%
3,656,789
+3,551,050
+3,358% +$26.4M
2016 Q3
1 quarter
EMD icon
11
Western Asset Emerging Markets Debt Fund
EMD
$509M
$26.2M 2.66%
1,781,493
+1,285,703
+259% +$19.4M
2013 Q3
13 quarters
BGB icon
12
Blackstone Strategic Credit 2027 Term Fund
BGB
$487M
$23.4M 2.38%
1,524,251
-1,452,326
-49% -$21.6M
2013 Q4
12 quarters
GLQ icon
13
Clough Global Equity Fund
GLQ
$129M
$21.8M 2.21%
+1,960,479
New +$21.3M
2016 Q4
0 quarters
TSLA icon
14
PUT
Tesla
TSLA
$1.37T
$21.4M 2.17%
+1,500,000
New +$19.7M
2016 Q4
0 quarters
APC icon
15
PUT
DELISTED
Anadarko Petroleum
APC
$21.1M 2.14%
302,100
– –
2015 Q4
4 quarters
GLV icon
16
Clough Global Dividend & Income Fund
GLV
$67.1M
$19.2M 1.95%
+1,596,881
New +$18.7M
2016 Q4
0 quarters
CYH icon
17
Community Health Systems
CYH
$228M
$19M 1.94%
3,405,469
+2,080,294
+157% +$14.4M
2016 Q1
3 quarters
CIK icon
18
UBS Asset Management Income Fund
CIK
$125M
$18.8M 1.91%
5,945,208
+36,031
+0.6% +$111K
2013 Q4
12 quarters
SDRL icon
19
PUT
DELISTED
Seadrill
SDRL
$17.7M 1.8%
19,387
-1,203
-6% -$880K
2016 Q1
3 quarters
GLO icon
20
Clough Global Opportunities Fund
GLO
$216M
$17M 1.73%
1,904,876
+1,880,608
+7,749% +$17M
2014 Q4
8 quarters
KMM
21
DELISTED
Deutsche Multi-Market Income Trust
KMM
$16.7M 1.7%
1,960,714
– –
2013 Q4
12 quarters
BWG icon
22
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$107M
$16.3M 1.65%
1,374,096
+3,400
+0.2% +$41.8K
2013 Q3
13 quarters
NFJ icon
23
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.19B
$16.2M 1.65%
1,287,419
-3,050
-0.2% -$38.2K
2016 Q1
3 quarters
BHC icon
24
Bausch Health
BHC
$3.08B
$14.5M 1.47%
996,589
+549,238
+123% +$10.1M
2016 Q1
3 quarters
EOD icon
25
Allspring Global Dividend Opportunity Fund
EOD
$246M
$14.1M 1.43%
+2,583,733
New +$14M
2016 Q4
0 quarters

Similar funds

Boaz Weinstein's Q4 2016 Portfolio in Review

As of Q4 2016, Boaz Weinstein held 114 positions worth $984M, down 3.9% from $1.02B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Boaz Weinstein deployed $91M of net new capital in Q4 2016, opening 17 new positions and adding to 26 existing holdings. Its largest new stake was Allergan plc: 155,521 shares worth $32.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Blackstone Strategic Credit 2027 Term Fund, an estimated $21.6M trimmed.

  • Boaz Weinstein's largest Q4 2016 buy was Allergan plc: 155,521 shares worth $32.7M.
  • Boaz Weinstein added most to abrdn Total Dynamic Dividend Fund in Q4 2016, an estimated $26.4M increase.
  • Boaz Weinstein's biggest Q4 2016 reduction was Blackstone Strategic Credit 2027 Term Fund, cutting an estimated $21.6M.
  • Boaz Weinstein fully exited Western Asset Emerging Markets in Q4 2016, selling an estimated $23M.
  • Boaz Weinstein's ten largest holdings make up 49% of its $984M portfolio in Q4 2016.
  • Boaz Weinstein opened 17 new positions and closed 20 in Q4 2016.
  • Boaz Weinstein's portfolio value fell 3.9% quarter-over-quarter to $984M.

Based on Saba Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.